Plantar Fasciitis Treatment Market Size (2024 - 2029)

Plantar Fasciitis Treatment Market Analysis

The plantar fasciitis treatment market is expected to register a CAGR of nearly 6.8% during the forecast period.

The COVID-19 outbreak was an unprecedented health concern and had significantly impacted the plantar fasciitis treatment market worldwide. Sports have been classified based on their contact nature. Thus, several sports activities were on hold, and some were postponed during the pandemic, thereby impacting the growth of the market in the first quarter of 2020. For instance, according to an April 2021 update by the NSC in America, the Consumer Product Safety Commission (CPSC) reported that during the first seven months of the COVID-19 pandemic, visits to emergency departments for consumer product-related injuries fell by 24%. The highest decrease in injuries was sports-related injuries associated with track and field. Hockey, soccer, baseball, football, and basketball witnessed a more than 60% reduction from March through September 2020. However, the post-COVID-19 situation is likely to have huge growth as pending procedures will increase in the surgical volume. The market was impacted at the beginning of the pandemic; however, post-COVID-19, it has stabilized.

The increasing adoption of orthotics techniques coupled with an increasing number of plantar fasciitis cases is the major factor driving the growth of the market globally.

According to the study published in May 2022 by the National Library of Medicine, approximately one million patient visits per year are due to plantar fasciitis. This condition accounts for about 10% of runner-related injuries and 11% to 15% of all foot symptoms requiring professional medical care. It is thought to occur in about 10% of the general population as well, with 83% of these patients being active working adults between the ages of 25 and 65 years old. It may be present bilaterally in a third of the cases.

Moreover, according to the CDC data updated in January 2022, unintentional injury accounted for 200,995 in 2020, and the number of deaths due to traffic accidents was reported to be 40,698 in the United States in the same year. According to the same data, 24.8 million physician visits and 97.9 million emergency department visits occurred in 2020 in the United States. Thus, high cases of various injuries indicate a higher number of people suffering from plantar fasciitis, thereby driving the growth of the global market.

Furthermore, the increasing geriatric population, growing technological advancements, and availability of various treatment options are also a few factors fueling the growth of the plantar fasciitis treatment market. However, the high cost of the treatment and lack of awareness about the plantar fasciitis condition is hindering the growth of the market.

Plantar Fasciitis Treatment Industry Segmentation

As per the scope of the report, plantar fasciitis is the most common cause of heel pain. Plantar fasciitis occurs when the strong band of tissue that supports the arch of your foot becomes irritated and inflamed. The Plantar Fasciitis Treatment Market is segmented by Treatment Type (Pharmacological Treatment, Orthotic Devices, Shockwave Therapy, Surgery, and Other Treatment Types), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.